2010
DOI: 10.1002/jso.21729
|View full text |Cite
|
Sign up to set email alerts
|

Role of FDG‐PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer

Abstract: Staging by FDG-PET of patients who are candidates for surgical treatment of colorectal metastases is an essential part of management of this problem. FDG-PET is highly sensitive and specific for intrahepatic colorectal tumors and the most sensitive test for extrahepatic tumors. FDG-PET alters management in 25% of patients, reducing futile laparotomies and hepatectomies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
9
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 42 publications
1
9
0
2
Order By: Relevance
“…In some patients, the 30 min extra scanner time necessary for the RGL-PET and PL-PET may change clinical management of potentially resectable colorectal liver metastases by either preventing futile laparotomies or by leading to a change in surgical strategy. Moreover, the study confirms the importance of performing a 18F-FDG PET before surgical resection of colorectal liver metastases to rule out extrahepatic malignancy and to confirm the CT findings of liver lesions suspicious of malignancy (6,7,14).…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…In some patients, the 30 min extra scanner time necessary for the RGL-PET and PL-PET may change clinical management of potentially resectable colorectal liver metastases by either preventing futile laparotomies or by leading to a change in surgical strategy. Moreover, the study confirms the importance of performing a 18F-FDG PET before surgical resection of colorectal liver metastases to rule out extrahepatic malignancy and to confirm the CT findings of liver lesions suspicious of malignancy (6,7,14).…”
Section: Discussionsupporting
confidence: 71%
“…Accurate diagnostic imaging in the preoperative assessment of patients with potentially resectable colorectal liver metastases is essential in order to identify candidates for curative liver surgery (6,7). Current guidelines (October 2013) from the National Comprehensive Cancer Network (NCCN) recommend a staging 2-deoxy-2-(18F)fluoro-D-Glucose positron emission tomography (18F-FDG PET) examination for patients with potentially surgically curable metastatic colorectal cancer (8).…”
Section: Introductionmentioning
confidence: 99%
“…The specificity of the radiolabel is important for accurately marking a target tissue for imaging. In particular, PET imaging with 2′-[ 18 F]fluorodeoxyglucose ( 18 FDG PET) has become a useful tool in the evaluation of tumor lesions, particularly for pancreatic cancer, and the discovery of distant metastases [5], [6], [7], [8]. 18 FDG is a glucose analog that is taken up avidly by rapidly growing malignant masses, but not all hot spots are cancerous.…”
Section: Introductionmentioning
confidence: 99%
“…18 F]fluorodeoxyglucose ( 18 FDG PET) has become a useful tool in the evaluation of tumor lesions, particularly for pancreatic cancer, and the discovery of distant metastases [40][41][42][43]. 18 FDG is a glucose analog that is taken up aggressively by rapidly growing malignant masses, but not all hot spots are cancerous.…”
Section: Discussionmentioning
confidence: 99%